Pulmonary Disease Doctors in Duluth, MN Accepting Medicare

7 Pulmonary Disease doctors found. Showing 1 - 7

Dr. Joseph J Martinelli, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 920 E 1st St, Ste P201, Duluth, MN 55805 Phone: 218-249-7970

Dr. Gregory Robert Stroh, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 400 E 3rd St, Duluth, MN 55805 Phone: 218-786-8364

Jeray James Johnson, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 920 E 1st St, P201, Duluth, MN 55805 Phone: 218-249-7970    Fax: 218-249-7949

Peter Karl Franklin, Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 400 E 3rd St, Duluth, MN 55805 Phone: 218-786-8364

Dr. Vance David Bachelder, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 920 E 1st St, Suite L201, Duluth, MN 55805 Phone: 218-249-7970

Dr. Wayne Alan Elmer, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 920 E 1st St, Suite 201, Duluth, MN 55805 Phone: 218-249-7970    Fax: 218-249-7997

Terrence Charles Clark, Internal Medicine - Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 400 E 3rd St, Duluth, MN 55805 Phone: 218-786-8364

News Archive

New research may help clinicians determine factors that increase risk of blood clots after surgery

New research from the UC Davis Comprehensive Cancer Center, published in the Journal of Surgical Research, may help clinicians determine which patients are at highest risk for post-surgical blood clots in the legs or lungs.

Researchers reveal how toxins turn healthy proteins into poison to disrupt immune response

Researchers who have revealed a highly efficient way that bacteria use toxins to interrupt the immune response say that until now, the trickery of these toxins has been underappreciated in science.

Cell Therapeutics agrees to sell $20M of Series 4 Preferred Stock and warrants to institutional investors

Cell Therapeutics, Inc. today announced that it has entered into an agreement to sell $20 million of shares of its Series 4 Preferred Stock and warrants to purchase shares of its common stock in a registered offering to three institutional investors.

Columbia University's imaging software gets FDA 510k clearance

Columbia University's imaging software that facilitates 3-D lung tumor segmentation, licensed to Varian Medical Systems, has been incorporated into the Smart Segmentation module of Varian's Eclipse treatment planning system and has received FDA 510k clearance.

Morinaga Milk's probiotic B. breve A1 improves memory functions of older adults with MCI

Morinaga Milk Industry Co., Ltd., a leading Japanese dairy product company and a key global probiotics manufacturer, confirmed that its proprietary probiotic strain Bifidobacterium breve A1 (a.k.a. B. breve MCC1274) is safe and effective for improving memory functions of older adults with suspected mild cognitive impairment (MCI) in a randomized, double-blind, placebo-controlled trial (RCT).

Read more Medical News

› Verified 6 days ago